Home > Healthcare & Medical Devices > Extracorporeal Membrane Oxygenation (ECMO) Market

Extracorporeal Membrane Oxygenation (ECMO) Market Size By Modality (Venoarterial, Veno-venous, Arteriovenous), By Application (Cardiac, Respiratory, Extracorporeal Cardiopulmonary Resuscitation), By Patient Population (Infant, Pediatric, Adult), Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 – 2032

  • Report ID: GMI2720
  • Published Date: Dec 2022
  • Report Format: PDF

Industry Statistics

Extracorporeal Membrane Oxygenation Market recorded a valuation worth over USD 490 million in 2022. Due to the surging incidences of respiratory failure and cardiopulmonary diseases, the industry is expected to depict more than 3% CAGR from 2023 to 2032.

Growing inclination towards unhealthy lifestyles and the increased uptake of tobacco and alcohol across the Asia Pacific region has resulted in the growing prevalence of lung and heart disorders. The widely expanding patient pool across countries such as China and India will propel the adoption of advanced ECMO devices.

Get more details on this report - Request Free Sample PDF

In addition, the increasing technological breakthroughs in existing ECMO devices across developed markets, such as North America, focused on developing systems with improved portability, efficiency, and added features, will favor ECMO market growth.

High costs associated with the product may act as a restraining factor

ECMO devices usually associate high costs, which limits their sales across developing and underdeveloped economies. The mean estimated total hospital costs, including pre-ECMO and post-ECMO procedures, stand at 213,246 USD. The increasing dependence of people across these economies on other inexpensive alternatives may impede market revenues. Furthermore, the potential risks, such as hemorrhage, associated with prolonged usage of life-supporting devices may hamper market sshare.

Increasing technological advancements to boost the adoption of the arteriovenous approach

Extracorporeal membrane oxygenation market from arteriovenous (AV) segment is anticipated to grow at a 3.5% CAGR between 2023 and 2032. Arteriovenous ECMO has emerged as an effective life-saving therapeutic approach to treat patients with pulmonary embolism. The remarkable growth in demand for technologically advanced equipment and therapies propelled by the increasing burden of cardiovascular diseases and pulmonary disorders will create a positive growth outlook for the ECMO industry.

ECPR technique to gain momentum due to the growing prevalence of sudden cardiac arrests

Get more details on this report - Request Free Sample PDF

With respect to type, the extracorporeal cardiopulmonary resuscitation (ECPR) segment is projected to amass over 5% ECMO market share by 2032. ECPR technique is used in patients having unexpected or sudden pulselessness caused by the cessation of cardiac mechanical activity. According to the guidelines published by the American Heart Association (AHA)and the Extracorporeal Life Support Organization (ELSO), the procedure is prescribed to limited patients suffering from cardiac arrests. The increasing incidences of sudden cardiac arrests will foster the adoption of ECPR.

Surging incidences of chronic diseases among the pediatric population to boost market statistics

Get more details on this report - Request Free Sample PDF

Extracorporeal membrane oxygenation market from pediatric segment amassed over USD 100 million in 2022. The extensive usage of ECMO devices in treating several pediatric diseases, such as pneumonia, meconium aspiration syndrome, respiratory distress syndrome (RDS), and congenital diaphragmatic hernia (CDH). The Extracorporeal Life Support Organization (ELSO) registry suggests that over 33,000 pediatric patients received ECMO support worldwide in 2021. The growing prevalence of chronic and infectious diseases among the pediatric population will augment market forecasts.

Increasing R&D initiatives to accelerate business trends across North America

Get more details on this report - Request Free Sample PDF

North America extracorporeal membrane oxygenation market held over 58% busniess share in 2022 and is poised to record a sizeable valuation by 2032. The increased adoption of unhealthy lifestyles such as smoking and tobacco consumption and the consistent expansion of the geriatric population base will stimulate regional industry outlook. Besides, the rising healthcare expenditure and increasing R&D investments focused on integrating advanced technologies in the existing ECMO devices will support regional expansion.

Increasing technological innovations to strengthen the competitive landscape

Terumo Corporation, Abbott Laboratories, Braile Biomedica, Fresenius Medical Care AG & Co. KGaA, Edwards Lifesciences Corporation, Euro sets, Abiomed, Getinge AB, Medtronic, LivaNova PLC, MicroPort Scientific Corporation, SB-Kawasumi Laboratories, Inc., Nipro, and Spectrum Medical, are the notable players operating in the ECMO market. These companies have been undertaking R&D initiatives to introduce breakthrough developments and strengthen their market position.

Impact of COVID-19 on the extracorporeal membrane oxygenation market value

The COVID-19 pandemic had a positive impact on the ECMO industry. The sudden upsurge in COVID-19 infections across several developing economies for over a year resulted in the continued requirement for extra life support, thus driving the demand for ECMO machines. As per the American College of Cardiology (ACC), an estimated 40% of patients who recuperated from COVID-19 developed some form of cardiovascular condition. Thus, the increased adoption of ECMO machines to mitigate the severity and mortality risk associated with the diseases further accentuated business growth during the crisis.

The ECMO market report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments:

By Modality

  • Venoarterial
  • Veno-venous
  • Arteriovenous

By Application

  • Cardiac
  • Respiratory
  • Extracorporeal cardiopulmonary resuscitation

By Patient Population

  • Infant
  • Pediatric
  • Adult

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Taiwan
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • Others


Authors: Sumant Ugalmugle, Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for ECMO stood at over USD 490 million in 2022 and is expanding consistently at more than 3% CAGR driven by the increasing prevalence of respiratory failure and cardiopulmonary diseases.
Extracorporeal cardiopulmonary resuscitation (ECPR) segment is expected to accumulate over 5% market share by 2032 owing to the increasing incidences of sudden cardiac arrests.
Ppediatric segment garnered over USD 100 million in 2022 driven by the increasing prevalence of several pediatric diseases, such as pneumonia, meconium aspiration syndrome, respiratory distress syndrome (RDS), and congenital diaphragmatic hernia (CDH).
North America amassed over 58% share of ECMO market in 2022 due to the increasing elderly populace and the considerable growth in healthcare expenditure across the region.

Buy Now

Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 196
  • Countries covered: 19
  • Pages: 145
  • Upcoming Report: Details can be customized to meet your information and data needs. Feel free to share your detailed research requirements via this form.

Get a report that explains COVID-19 impact on this market

 Request Free Sample

Budget constraints? Get in touch with us for special pricing

Request Discount